• StockNews.com Initiates Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS) Defense World Mon, 05 May 2025 06:28:21 GMT
• japan tobacco inc. (otcmkts:japaf) short interest down 48.6% in april American Banking and Market News Mon, 28 Apr 2025 11:16:40 GMT
• Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com Defense World Sun, 27 Apr 2025 06:08:23 GMT
• desmoid tumors treatment market size in 7mm is expected to grow at a decent cagr by 2034, estimates delveinsight The Globe and Mail Tue, 22 Apr 2025 05:54:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Sat, 19 Apr 2025 07:00:00 GMT
• reflecting on traditional media & publishing stocks’ q4 earnings: sinclair (nasdaq:sbgi) The Globe and Mail Fri, 18 Apr 2025 09:06:00 GMT
• OS Therapies: Acquisition Of Advaxis Immunotherapies Assets Completed Pulse 2.0 Sat, 12 Apr 2025 03:46:57 GMT
• ayala pharmaceuticals (nasdaq:adxs) earns sell rating from analysts at stocknews.com Defense World Fri, 11 Apr 2025 07:00:00 GMT
• Sector Update: Health Care Stocks Rise Wednesday Afternoon TradingView Wed, 09 Apr 2025 18:19:11 GMT
• os therapies acquire advaxis immunotherapies clinical, pre-clinical and ip assets from ayala pharmaceuticals citybiz Wed, 09 Apr 2025 13:31:08 GMT
• OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals Business Wire Wed, 09 Apr 2025 07:00:00 GMT
• OS Therapies Finalizes Acquisition of Advaxis Assets From Ayala Pharmaceuticals marketscreener.com Wed, 09 Apr 2025 07:00:00 GMT
• os therapies acquires advaxis immunotherapies assets by investing.com Investing.com India Wed, 09 Apr 2025 07:00:00 GMT
• major cancer immunotherapy acquisition: os therapies gains 11 new cancer-fighting assets Stock Titan Wed, 09 Apr 2025 07:00:00 GMT
• Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com Defense World Thu, 03 Apr 2025 07:00:00 GMT
• os therapies to showcase accelerated approval strategy for cancer programs at nyse Stock Titan Wed, 02 Apr 2025 07:00:00 GMT
• os therapies reports full year 2024 financial results and provides business update BioSpace Tue, 01 Apr 2025 07:00:00 GMT
• OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update Business Wire Mon, 31 Mar 2025 07:00:00 GMT
• stocknews.com initiates coverage on ayala pharmaceuticals (nasdaq:adxs) Defense World Wed, 26 Mar 2025 06:07:11 GMT
• stocknews.com initiates coverage on ayala pharmaceuticals (nasdaq:adxs) Defense World Tue, 18 Mar 2025 07:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated at stocknews.com The AM Reporter Tue, 11 Mar 2025 07:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Mon, 10 Mar 2025 07:00:00 GMT
• davidstea (nasdaq:dtea) now covered by analysts at stocknews.com Defense World Mon, 10 Mar 2025 07:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) earns sell rating from analysts at stocknews.com Defense World Sun, 02 Mar 2025 07:30:47 GMT
• ayala pharmaceuticals (nasdaq:adxs) now covered by stocknews.com Defense World Sat, 22 Feb 2025 08:00:00 GMT
• small-cap os therapies inks commercial manufacture agreements for lead cancer drug for rare type of bone cancer Benzinga India Sat, 15 Feb 2025 08:00:00 GMT
• small-cap os therapies inks commercial manufacture agreements for lead cancer drug for rare type of bone cancer Benzinga Fri, 14 Feb 2025 08:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Fri, 14 Feb 2025 06:36:05 GMT
• up manila and ayala conglomerate forge alliance to advance healthcare education and research upm.edu.ph Thu, 13 Feb 2025 06:07:20 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated at stocknews.com Defense World Sat, 08 Feb 2025 08:00:00 GMT
• deal watch: novo nordisk, immvention to partner on sickle cell disease insights.citeline.com Wed, 05 Feb 2025 08:00:00 GMT
• Rockville's OS Therapies acquires rights to key drugs, eyes FDA approval for cancer therapy The Business Journals Tue, 04 Feb 2025 08:00:00 GMT
• os therapies acquires key ip from ayala pharmaceuticals - washington business journal The Business Journals Tue, 04 Feb 2025 08:00:00 GMT
• adxs (ayala pharmaceuticals) 5-year dividend growth rate : 0.00% (as of dec. 2023) GuruFocus.com Sat, 01 Feb 2025 22:20:41 GMT
• os therapies agrees to acquire all listeria monotygenes-based immuno-oncology programs and ip assets from ayala pharmaceuticals: m... Defense World Fri, 31 Jan 2025 08:00:00 GMT
• os therapies incorporated agreed to acquire immuno-oncology programs and ip assets from ayala pharmaceuticals, inc. for $8 million... Marketscreener.com Thu, 30 Jan 2025 18:25:34 GMT
• os therapies to acquire listeria programs from ayala pharmaceuticals Yahoo Finance Thu, 30 Jan 2025 08:00:00 GMT
• desmoid tumors market to show remarkable growth trends from 2024 to 2034, delveinsight reports EIN News Wed, 29 Jan 2025 19:42:00 GMT
• OS Therapies pays $8M for full IP rights to its lead drug, gains 2 more cancer assets in the process Fierce Biotech Wed, 29 Jan 2025 08:00:00 GMT
• OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, A... Business Wire Wed, 29 Jan 2025 08:00:00 GMT
• game-changing cancer pipeline deal: os therapies adds lung & prostate programs for just $8m Stock Titan Wed, 29 Jan 2025 08:00:00 GMT
• os therapies to acquire listeria programs from ayala pharmaceuticals TipRanks Wed, 29 Jan 2025 08:00:00 GMT
• os therapies makes strategic move: snaps up advanced cancer programs at bargain price Stock Titan Wed, 29 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on ayala pharmaceuticals (nasdaq:adxs) Defense World Wed, 29 Jan 2025 08:00:00 GMT
• os therapies to acquire certain ayala pharmaceuticals assets -january 29, 2025 at 10:58 am est Marketscreener.com Wed, 29 Jan 2025 08:00:00 GMT
• os therapies incorporated agreed to acquire immuno-oncology programs and ip assets from ayala pharmaceuticals, inc. for $8 million... Marketscreener.com Tue, 28 Jan 2025 23:00:00 GMT
• advaxis, inc. announces unaudited earnings results for the three months and six months ended april 30, 2019 Marketscreener.com Thu, 23 Jan 2025 14:53:55 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Tue, 21 Jan 2025 08:00:00 GMT
• os therapies heading to fda with positive osteosarcoma data BioWorld Online Wed, 15 Jan 2025 08:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Mon, 13 Jan 2025 22:53:05 GMT
• desmoid tumors market to reach new heights in growth by 2034, openPR Mon, 06 Jan 2025 08:00:00 GMT
• smart powerr (nasdaq:creg) coverage initiated by analysts at stocknews.com Defense World Sun, 05 Jan 2025 08:05:19 GMT
• ayala pharmaceuticals (nasdaq:adxs) now covered by analysts at stocknews.com Defense World Sun, 05 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on ata creativity global (nasdaq:aacg) Defense World Sun, 05 Jan 2025 08:00:00 GMT
• express (nyse:expr) coverage initiated by analysts at stocknews.com Defense World Sun, 05 Jan 2025 08:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated at stocknews.com Defense World Sat, 28 Dec 2024 08:57:45 GMT
• stocknews.com initiates coverage on ayala pharmaceuticals (nasdaq:adxs) Defense World Fri, 20 Dec 2024 12:37:45 GMT
• ayala corporation to secure funds worth €50 m for advancing healthcare growth in philippines BSA bureau Thu, 19 Dec 2024 08:00:00 GMT
• ayala corporation partners with ing to secure sustainable finance €50 million, advancing healthcare growth in the philippines Macau Business Wed, 18 Dec 2024 08:00:00 GMT
• metastatic triple negative breast cancer market expected to experience major growth by 2034, according to delveinsight | astrazene... Barchart Tue, 17 Dec 2024 18:17:18 GMT
• stocknews.com begins coverage on ata creativity global (nasdaq:aacg) Defense World Thu, 12 Dec 2024 09:42:57 GMT
• stocknews.com initiates coverage on xinyuan real estate (nyse:xin) Defense World Thu, 12 Dec 2024 08:08:06 GMT
• sunlink health systems (nyse:ssy) now covered by stocknews.com Defense World Wed, 04 Dec 2024 07:15:21 GMT
• atlantic american (nasdaq:aame) now covered by analysts at stocknews.com Defense World Wed, 04 Dec 2024 07:15:21 GMT
• china natural resources (nasdaq:chnr) coverage initiated at stocknews.com Defense World Wed, 20 Nov 2024 06:46:45 GMT
• stocknews.com begins coverage on euro tech (nasdaq:clwt) Defense World Wed, 20 Nov 2024 06:46:45 GMT
• stocknews.com initiates coverage on cumberland pharmaceuticals (nasdaq:cpix) Defense World Wed, 20 Nov 2024 06:46:45 GMT
• beasley broadcast group (nasdaq:bbgi) now covered by stocknews.com Defense World Sun, 10 Nov 2024 09:29:09 GMT
• art’s-way manufacturing (nasdaq:artw) now covered by analysts at stocknews.com Defense World Sun, 10 Nov 2024 07:37:30 GMT
• phx minerals (nyse:phx) coverage initiated by analysts at stocknews.com Defense World Sun, 10 Nov 2024 07:33:50 GMT
• adenoid cystic carcinoma market scope and competitive analysis openPR Wed, 06 Nov 2024 08:00:00 GMT
• bel fuse (nasdaq:belfb) downgraded by stocknews.com to “buy” Defense World Sat, 02 Nov 2024 16:59:44 GMT
• stocknews.com begins coverage on art’s-way manufacturing (nasdaq:artw) Defense World Sat, 02 Nov 2024 16:44:51 GMT
• advaxis announces receipt of funding milestone payment under adxs-her2 licensing agreement with os therapies Marketscreener.com Thu, 31 Oct 2024 02:08:38 GMT
• set to open in 2026: ayala-backed pharma distributor expands operations with new cavite technopark warehouse Bilyonaryo Business News Mon, 28 Oct 2024 07:00:00 GMT
• desmoid tumors market drivers 2024-2033: demand, insights, and overview WhaTech Fri, 25 Oct 2024 13:49:01 GMT
• baidu (nasdaq:bidu) rating lowered to hold at stocknews.com Defense World Fri, 25 Oct 2024 07:00:00 GMT
• advaxis (adxs) sees 112.96% surge amid market volatility GuruFocus.com Tue, 22 Oct 2024 20:15:40 GMT
• set to open in 2026: ayala-backed pharma distributor expands operations with new cavite technopark warehouse Bilyonaryo Business News Mon, 21 Oct 2024 07:00:00 GMT
• asia pacific wire & cable (nasdaq:apwc) now covered by analysts at stocknews.com Defense World Thu, 17 Oct 2024 06:09:22 GMT
• ayala pharmaceuticals (nasdaq:adxs) research coverage started at stocknews.com Defense World Thu, 17 Oct 2024 06:09:22 GMT
• triple-negative breast cancer market to observe stupendous growth during the study period (2020–2034) | delveinsight The Globe and Mail Tue, 08 Oct 2024 07:00:00 GMT
• set to open in 2026: ayala-backed pharma distributor expands operations with new cavite technopark warehouse Bilyonaryo Business News Fri, 04 Oct 2024 07:00:00 GMT
• research analysts’ new coverage for october 1st (aacg, aame, aan, adxs, aktx, apwc, arc, artw, avgr, bbgi) Defense World Tue, 01 Oct 2024 21:00:50 GMT
• ayala pharmaceuticals (nasdaq:adxs) now covered by analysts at stocknews.com Defense World Tue, 01 Oct 2024 06:12:02 GMT
• calavo growers, inc. (cvgw) to issue quarterly dividend of $0.20 on october 30th Defense World Tue, 01 Oct 2024 06:09:55 GMT
• micron technology, inc. (nasdaq:mu) stake lowered by cmg global holdings llc Defense World Tue, 01 Oct 2024 06:09:35 GMT
• pacer advisors inc. has $2.90 million holdings in hess co. (nyse:hes) Defense World Thu, 26 Sep 2024 07:00:00 GMT
• wellchange holdings plans $9 million ipo for september 27th (wct) Defense World Mon, 23 Sep 2024 07:00:00 GMT
• reviewing koninklijke vopak (otc:vopkf) and oneok (nyse:oke) Defense World Mon, 23 Sep 2024 07:00:00 GMT
• starbucks co. (nasdaq:sbux) receives average recommendation of “moderate buy” from analysts Defense World Mon, 23 Sep 2024 06:33:09 GMT
• scilex (nasdaq:sclx) and prime medicine (nyse:prme) critical analysis Defense World Mon, 23 Sep 2024 06:25:52 GMT
• seachange international (nasdaq:seac) coverage initiated at stocknews.com Defense World Mon, 23 Sep 2024 06:15:06 GMT
• macy’s (nyse:m) receives new coverage from analysts at stocknews.com Defense World Mon, 23 Sep 2024 06:10:49 GMT
• telsey advisory group equities analysts reduce earnings estimates for h & m hennes & mauritz ab (publ) (otcmkts:hnnmy) Defense World Mon, 23 Sep 2024 05:39:20 GMT
• barrow hanley mewhinney & strauss llc lowers holdings in vertiv holdings co (nyse:vrt) Defense World Mon, 23 Sep 2024 01:37:08 GMT
• vanguard s&p 500 etf (nysearca:voo) is ironclad investments llc’s 2nd largest position Defense World Sun, 22 Sep 2024 18:32:32 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated by analysts at stocknews.com Defense World Mon, 16 Sep 2024 09:43:26 GMT
• nomad foods limited (nyse:nomd) stock position lifted by national bank of canada fi Defense World Mon, 16 Sep 2024 08:03:48 GMT
• uk government moves to ban ‘zombie drug’ xylazine Bilyonaryo Business News Thu, 05 Sep 2024 07:00:00 GMT
• ayala pharmaceuticals files form 15 to voluntarily deregister and suspend its reporting obligations GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• asco reading room | jennifer litton, md, on defining endpoints for neoadjuvant breast cancer trials Medpage Today Tue, 03 Sep 2024 07:00:00 GMT
• china natural resources (nasdaq:chnr) now covered by analysts at stocknews.com Defense World Fri, 30 Aug 2024 06:19:21 GMT
• ayala pharmaceuticals (nasdaq:adxs) coverage initiated at stocknews.com Defense World Fri, 30 Aug 2024 06:19:21 GMT
• euro tech (nasdaq:clwt) coverage initiated at stocknews.com Defense World Fri, 30 Aug 2024 06:19:21 GMT
• smart powerr (nasdaq:creg) earns sell rating from analysts at stocknews.com Defense World Fri, 30 Aug 2024 06:19:21 GMT
• cumberland pharmaceuticals (nasdaq:cpix) earns hold rating from analysts at stocknews.com Defense World Fri, 30 Aug 2024 06:19:21 GMT
• desmoid tumors market - exploration trends, analysis, growth prospects and forecast 2033 WhaTech Technology and Markets News Wed, 28 Aug 2024 04:48:39 GMT
• ayala pharmaceuticals (stu:fad) debt-to-equity : -0.34 (as of dec. 2023) GuruFocus.com Mon, 19 Aug 2024 21:39:22 GMT
• ayala pharmaceuticals (stu:fad) earnings yield % : n/a% (as of aug. 19, 2024) GuruFocus.com Mon, 19 Aug 2024 10:00:51 GMT
• ayala pharmaceuticals (stu:fad) debt-to-ebitda : -0.24 (as of dec. 2023) GuruFocus.com Mon, 19 Aug 2024 09:57:57 GMT
• ayala pharmaceuticals (stu:fad) 3-year eps without nri grow GuruFocus.com Mon, 19 Aug 2024 09:55:56 GMT
• ayala pharmaceuticals (stu:fad) cash flow from investing : €0.00 mil (ttm as of dec. 2023) GuruFocus.com Mon, 19 Aug 2024 09:51:39 GMT
• gsk wins latest us litigation over zantac drug saga Bilyonaryo Business News Fri, 16 Aug 2024 07:00:00 GMT
• adenoid cystic carcinoma market to grow at a substantial growth openPR Thu, 15 Aug 2024 22:14:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) now covered by analysts at stocknews.com Defense World Wed, 14 Aug 2024 09:45:23 GMT
• weight-loss drug maker novo nordisk posts slight profit rise Bilyonaryo Business News Thu, 08 Aug 2024 07:00:00 GMT
• expanding footprint: ayala group’s healthcare unit completes st. joseph drug investment Bilyonaryo Business News Tue, 06 Aug 2024 07:00:00 GMT
• ayala pharmaceuticals (nasdaq:adxs) now covered by analysts at stocknews.com Defense World Tue, 06 Aug 2024 06:37:44 GMT
• expansion plans on the table: ayala group eyes $500 million valuation for ac healthcare in potential minority stake sale Bilyonaryo Business News Sun, 04 Aug 2024 07:00:00 GMT
• philippines' ayala explores minority stake sale in ac health, sources say Reuters Thu, 01 Aug 2024 07:00:00 GMT
• ayala explores minority stake sale in ac health, sources say Interaksyon Thu, 01 Aug 2024 07:00:00 GMT
• who are the leading innovators in personalized cancer vaccines for the pharmaceutical industry? Pharmaceutical Technology Tue, 30 Jul 2024 07:00:00 GMT
• stocknews.com initiates coverage on ayala pharmaceuticals (nasdaq:adxs) Defense World Mon, 29 Jul 2024 08:04:09 GMT
• stocknews.com initiates coverage on ayala pharmaceuticals (nasdaq:adxs) American Banking and Market News Mon, 22 Jul 2024 11:01:22 GMT
Ayala Pharmaceuticals, Inc(NASDAQ:AYLA) 
Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gam...
Website: http://www.ayalapharma.com
Founded: 2017
Full Time Employees: 34 (May 2021)
CEO: Roni Mamluk
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends